TPTX » Topics » GRANTS OF PLAN-BASED AWARDS IN 2008

This excerpt taken from the TPTX DEF 14A filed Jun 19, 2009.

GRANTS OF PLAN-BASED AWARDS IN 2008

 

        Estimated Possible Payouts
Under Non-Equity Incentive
Plan Awards(1)
  All Other
Option
Awards:
Number of
Securities
Underlying

Options
(2)(#)
  Exercise or
Base Price
of Option

Awards
($/Sh)
  Grant Date
Fair Value
of Stock
and Option

Awards
(3)($)

Name

  Grant
Date
  Threshold
($)
  Target
($)
  Maximum
($)
     

Evelyn A. Graham

  10/15/08   —     —     —     300,000   0.27   53,580
  n/a   110,250   157,500   236,250   —     —     —  

Craig A. Johnson

  10/15/08   —     —     —     250,000   0.27   44,650
  n/a   59,220   84,600   126,900   —     —     —  

Paul R. Schneider

  10/15/08   —     —     —     120,000   0.27   21,432
    38,098   54,425   81,638      

Susan J Mellberg

  10/15/08   —     —     —     120,000   0.27   21,432
    29,036   41,480   62,220      

Neil M. Kurtz, M.D.(4)

  n/a   131,418   187,740   281,610   —     —     —  

Steven L. Wagner, Ph.D.(5)

  n/a   42,858   61,225   91,838   —     —     —  

 

(1) The amounts shown in these columns represent the threshold, target and maximum payout levels for discretionary annual cash bonuses for 2008 performance. The actual amount of incentive bonus earned by each Named Executive Officer in 2008 was $0 and is reported under the Non-Equity Incentive Plan Compensation column in the Summary Compensation Table. The potential payouts for Named Executive Officers are performance driven and therefore are completely at risk.
(2) This column reflects the number of stock options granted under our 2006 Plan during 2008. The terms of these awards are summarized in the “Outstanding Equity Awards at Fiscal Year-End Table” below.
(3) Amount represents the grant date fair value for stock options granted under our 2006 Plan during 2008 and is computed in accordance with FAS 123R. Assumptions used in the calculation of these amounts are included in the footnotes of the consolidated Financial Statements included in Part IV, Item 15, of this Annual Report on Form 10-K.
(4) Dr. Kurtz was our former President and Chief Executive Officer; he resigned from the Company effective August 31, 2008.
(5) Dr. Wagner was our former Chief Scientific Officer; his last date of employment was September 30, 2008.

 

54


Table of Contents
This excerpt taken from the TPTX 10-K filed Mar 27, 2009.

GRANTS OF PLAN-BASED AWARDS IN 2008

 

        Estimated Possible Payouts
Under Non-Equity Incentive
Plan Awards(1)
  All Other
Option
Awards:
Number of
Securities
Underlying

Options
(2)(#)
  Exercise or
Base Price
of Option

Awards
($/Sh)
  Grant Date
Fair Value
of Stock
and Option

Awards
(3)($)

Name

  Grant
Date
  Threshold
($)
  Target
($)
  Maximum
($)
     

Evelyn A. Graham

  10/15/08   —     —     —     300,000   0.27   53,580
  n/a   110,250   157,500   236,250   —     —     —  

Craig A. Johnson

  10/15/08   —     —     —     250,000   0.27   44,650
  n/a   59,220   84,600   126,900   —     —     —  

Paul R. Schneider

  10/15/08   —     —     —     120,000   0.27   21,432
    38,098   54,425   81,638      

Susan J Mellberg

  10/15/08   —     —     —     120,000   0.27   21,432
    29,036   41,480   62,220      

Neil M. Kurtz, M.D.(4)

  n/a   131,418   187,740   281,610   —     —     —  

Steven L. Wagner, Ph.D.(5)

  n/a   42,858   61,225   91,838   —     —     —  

 

(1) The amounts shown in these columns represent the threshold, target and maximum payout levels for discretionary annual cash bonuses for 2008 performance. The actual amount of incentive bonus earned by each Named Executive Officer in 2008 was $0 and is reported under the Non-Equity Incentive Plan Compensation column in the Summary Compensation Table. The potential payouts for Named Executive Officers are performance driven and therefore are completely at risk.
(2) This column reflects the number of stock options granted under our 2006 Plan during 2008. The terms of these awards are summarized in the “Outstanding Equity Awards at Fiscal Year-End Table” below.
(3) Amount represents the grant date fair value for stock options granted under our 2006 Plan during 2008 and is computed in accordance with FAS 123R. Assumptions used in the calculation of these amounts are included in the footnotes of the consolidated Financial Statements included in Part IV, Item 15, of this Annual Report on Form 10-K.
(4) Dr. Kurtz was our former President and Chief Executive Officer; he resigned from the Company effective August 31, 2008.
(5) Dr. Wagner was our former Chief Scientific Officer; his last date of employment was September 30, 2008.

 

54


Table of Contents

"GRANTS OF PLAN-BASED AWARDS IN 2008" elsewhere:

DEXTERA SURGICAL INC (CRDC)
Immunomedics (IMMU)
Monogram Biosciences (MGRM)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki